| |
|
|
|
Intec Pharma Ltd.  
|
|
0.77 0.045 (0.06%) |
10-16 16:00 |
|
Open: |
0.75 |
Pre close: |
0.725 |
Target:
|
1.42
|
|
High: |
0.8041 |
Low: |
0.75 |
Resistance:
|
1.21
1.56
|
|
Volume: |
493,837 |
Market Cap: |
26M |
Support:
|
0.65
0.54
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.74
 |
MACD |
MACD(12,26):
|
-0.04 |
|
MA(20): |
0.79  |
Signal(12,26,9): |
-0.04 |
|
MA(100): |
2.08 |
Stochastic Oscillator |
%K(14,3):
|
34.33 |
|
MA(250): |
4.98 |
%D(3): |
23.51 |
|
Average Volume(K) |
3-Month: |
229551
|
52-Week |
High:
|
9.25 |
|
10-Days: |
77012 |
Low: |
0.41 |
|
RSI |
RSI(14):
|
46.95 |
Change(%): |
-85.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.276 |
Return on Equity (ttm) |
-78.0 |
Shares Out. (M) |
33.30 |
|
EPS Est. Current Year |
-1.670 |
Return on Assets (ttm) |
-41.1 |
Shares Float (M) |
25.95 |
|
EPS Est. Next Year |
-1.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
16.08 |
|
EPS Est. Next Quarter |
-0.700 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
40.23 |
|
Forward EPS |
-1.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1390 |
|
Book Value (p.s.) |
1.050 |
EBITDA (p.s.) |
-1.256 |
P/E |
-0.60 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.73 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-36.95 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-24.45 |
P/CF |
-0.69 |
|
|
|
|
|
|
